147 related articles for article (PubMed ID: 38352981)
1. A dual-functional microfluidic chip for guiding personalized lung cancer medicine: combining EGFR mutation detection and organoid-based drug response test.
Zhang K; Xi J; Zhao H; Wang Y; Xue J; Liang N; Wei Z
Lab Chip; 2024 Mar; 24(6):1762-1774. PubMed ID: 38352981
[TBL] [Abstract][Full Text] [Related]
2. A Microfluidic Chip-Based Automated System for Whole-Course Monitoring the Drug Responses of Organoids.
Zhang K; Xi J; Wang Y; Xue J; Li B; Huang Z; Zheng Z; Liang N; Wei Z
Anal Chem; 2024 Jun; 96(24):10092-10101. PubMed ID: 38833634
[TBL] [Abstract][Full Text] [Related]
3. [Application and Research Progress of Lung Cancer Organoid in Precision Medicine
for Lung Cancer].
Huang Z; Li B; Wang Y; Xue J; Wei Z; Liang N; Li S
Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):276-282. PubMed ID: 38769830
[TBL] [Abstract][Full Text] [Related]
4. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
[TBL] [Abstract][Full Text] [Related]
5. Establishment of Colorectal Cancer Organoids in Microfluidic-Based System.
Pinho D; Santos D; Vila A; Carvalho S
Micromachines (Basel); 2021 Apr; 12(5):. PubMed ID: 33924829
[TBL] [Abstract][Full Text] [Related]
6. Drug screening on digital microfluidics for cancer precision medicine.
Zhai J; Liu Y; Ji W; Huang X; Wang P; Li Y; Li H; Wong AH; Zhou X; Chen P; Wang L; Yang N; Chen C; Chen H; Mak PI; Deng CX; Martins R; Yang M; Ho TY; Yi S; Yao H; Jia Y
Nat Commun; 2024 May; 15(1):4363. PubMed ID: 38778087
[TBL] [Abstract][Full Text] [Related]
7. Lung adenocarcinoma organoids harboring EGFR 19Del and L643V double mutations respond to osimertinib and gefitinib: A case report.
Bie Y; Wang J; Xiong L; Wang D; Liao J; Zhang Y; Lin H
Medicine (Baltimore); 2021 Mar; 100(11):e24793. PubMed ID: 33725945
[TBL] [Abstract][Full Text] [Related]
8. Prediction of TKI response in EGFR-mutant lung cancer patients-derived organoids using malignant pleural effusion.
Lee SH; Kim K; Lee E; Lee K; Ahn KH; Park H; Kim Y; Shin S; Jeon SY; Hwang Y; Ahn DH; Kwon YJ; Moon SW; Moon MH; Kim KS; Hyun K; Kim TJ; Sung YE; Choi JY; Park CK; Kim SW; Yeo CD; Sohn HJ; Hyun YS; Kim TG; Ku B; Lim JU; Kim SJ
NPJ Precis Oncol; 2024 May; 8(1):111. PubMed ID: 38773241
[TBL] [Abstract][Full Text] [Related]
9. OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening.
Deben C; De La Hoz EC; Compte ML; Van Schil P; Hendriks JMH; Lauwers P; Yogeswaran SK; Lardon F; Pauwels P; Van Laere S; Bogaerts A; Smits E; Vanlanduit S; Lin A
Cell Oncol (Dordr); 2023 Apr; 46(2):299-314. PubMed ID: 36508089
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis.
Westwood M; Joore M; Whiting P; van Asselt T; Ramaekers B; Armstrong N; Misso K; Severens J; Kleijnen J
Health Technol Assess; 2014 May; 18(32):1-166. PubMed ID: 24827857
[TBL] [Abstract][Full Text] [Related]
11. Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform.
Rajan SAP; Aleman J; Wan M; Pourhabibi Zarandi N; Nzou G; Murphy S; Bishop CE; Sadri-Ardekani H; Shupe T; Atala A; Hall AR; Skardal A
Acta Biomater; 2020 Apr; 106():124-135. PubMed ID: 32068138
[TBL] [Abstract][Full Text] [Related]
12. EGFR mutation detection of lung circulating tumor cells using a multifunctional microfluidic chip.
Wang Y; Gao W; Wu M; Zhang X; Liu W; Zhou Y; Jia C; Cong H; Chen X; Zhao J
Talanta; 2021 Apr; 225():122057. PubMed ID: 33592778
[TBL] [Abstract][Full Text] [Related]
13. Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank.
Zhou Z; Cong L; Cong X
Front Oncol; 2021; 11():762184. PubMed ID: 35036354
[TBL] [Abstract][Full Text] [Related]
14. MscI restriction enzyme cooperating recombinase-aided isothermal amplification for the ultrasensitive and rapid detection of low-abundance EGFR mutations on microfluidic chip.
Xu S; Wang X; Wu C; Zhu X; Deng X; Wu Y; Liu M; Huang X; Wu L; Huang H
Biosens Bioelectron; 2024 Mar; 247():115925. PubMed ID: 38134625
[TBL] [Abstract][Full Text] [Related]
15. Identifying EGFR-Expressed Cells and Detecting EGFR Multi-Mutations at Single-Cell Level by Microfluidic Chip.
Li R; Zhou M; Li J; Wang Z; Zhang W; Yue C; Ma Y; Peng H; Wei Z; Hu Z
Nanomicro Lett; 2018; 10(1):16. PubMed ID: 30393665
[TBL] [Abstract][Full Text] [Related]
16. Microfluidic Organoids-on-a-Chip: Quantum Leap in Cancer Research.
Duzagac F; Saorin G; Memeo L; Canzonieri V; Rizzolio F
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33578886
[TBL] [Abstract][Full Text] [Related]
17. In Situ Vitrification of Lung Cancer Organoids on a Microwell Array.
Liu Q; Zhao T; Wang X; Chen Z; Hu Y; Chen X
Micromachines (Basel); 2021 May; 12(6):. PubMed ID: 34071266
[TBL] [Abstract][Full Text] [Related]
18. Patient-derived organoids of lung cancer based on organoids-on-a-chip: enhancing clinical and translational applications.
Zeng X; Ma Q; Li XK; You LT; Li J; Fu X; You FM; Ren YF
Front Bioeng Biotechnol; 2023; 11():1205157. PubMed ID: 37304140
[TBL] [Abstract][Full Text] [Related]
19. Rapid determination of the presence of EGFR mutations with DNA-based nanocalipers.
Zhang K; Huang Z; Wang Y; Xue J; Liang N; Wei Z
Nanoscale; 2023 Aug; 15(33):13834-13841. PubMed ID: 37580989
[TBL] [Abstract][Full Text] [Related]
20. Mutation scanning using MUT-MAP, a high-throughput, microfluidic chip-based, multi-analyte panel.
Patel R; Tsan A; Tam R; Desai R; Spoerke J; Schoenbrunner N; Myers TW; Bauer K; Smith E; Raja R
PLoS One; 2012; 7(12):e51153. PubMed ID: 23284662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
